NSE: AUROPHARMA
|
BSE: 524804
1462.30
-1.30
(-0.09%)
1.4M
NSE+BSE Volume
NSE 05 Jun, 2026 3:31 PM (IST)
US FDA Approval
Aurobindo Pharma gets US FDA nod for an autoimmune disease treatment, with a market size of $494 mn
See details